-
1
-
-
84861617933
-
Review of hormonal treatment of breast cancer
-
Abdulkareem, I. H., and Zurmi, I. B. (2012). Review of hormonal treatment of breast cancer. Niger. J. Clin. Pract. 15, 9-14.
-
(2012)
Niger. J. Clin. Pract.
, vol.15
, pp. 9-14
-
-
Abdulkareem, I.H.1
Zurmi, I.B.2
-
2
-
-
67349176115
-
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
-
Ahren, B. (2009). Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug Discov. 8, 369-385.
-
(2009)
Nat. Rev. Drug Discov.
, vol.8
, pp. 369-385
-
-
Ahren, B.1
-
3
-
-
33847755409
-
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells
-
Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., et al. (2007). G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 67, 1859-1866.
-
(2007)
Cancer Res.
, vol.67
, pp. 1859-1866
-
-
Albanito, L.1
Madeo, A.2
Lappano, R.3
Vivacqua, A.4
Rago, V.5
Carpino, A.6
-
4
-
-
47949111993
-
Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells
-
Albanito, L., Sisci, D., Aquila, S., Brunelli, E., Vivacqua, A., Madeo, A., et al. (2008a). Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 149, 3799-3808.
-
(2008)
Endocrinology
, vol.149
, pp. 3799-3808
-
-
Albanito, L.1
Sisci, D.2
Aquila, S.3
Brunelli, E.4
Vivacqua, A.5
Madeo, A.6
-
5
-
-
58149331109
-
G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells
-
Albanito, L., Lappano, R., Madeo, A., Chimento, A., Prossnitz, E. R., Cappello, A. R., et al. (2008b). G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ. Health Perspect. 116, 1648-1655.
-
(2008)
Environ. Health Perspect.
, vol.116
, pp. 1648-1655
-
-
Albanito, L.1
Lappano, R.2
Madeo, A.3
Chimento, A.4
Prossnitz, E.R.5
Cappello, A.R.6
-
6
-
-
81355156238
-
Guide to receptors and channels (GRAC), 5th edition
-
Alexander, S. P., Mathie, A., and Peters, J. A. (2011). Guide to receptors and channels (GRAC), 5th edition. Br. J. Pharmacol. 164(Suppl. 1), S1-S324.
-
(2011)
Br. J. Pharmacol.
, vol.164
, Issue.SUPPL. 1
-
-
Alexander, S.P.1
Mathie, A.2
Peters, J.A.3
-
7
-
-
84872112695
-
The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells
-
Alonzeau, J., Alexandre, D., Jeandel, L., Courel, M., Hautot, C., Yamani, F. Z., et al. (2012). The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells. Eur. J. Cancer. 49, 511-519.
-
(2012)
Eur. J. Cancer.
, vol.49
, pp. 511-519
-
-
Alonzeau, J.1
Alexandre, D.2
Jeandel, L.3
Courel, M.4
Hautot, C.5
Yamani, F.Z.6
-
8
-
-
0036174608
-
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function
-
Angers, S., Salahpour, A., and Bouvier, M. (2002). Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435.
-
(2002)
Annu. Rev. Pharmacol. Toxicol.
, vol.42
, pp. 409-435
-
-
Angers, S.1
Salahpour, A.2
Bouvier, M.3
-
9
-
-
77950799867
-
Liraglutide (Victoza) for type 2 diabetes
-
Anonymous.
-
Anonymous. (2010). Liraglutide (Victoza) for type 2 diabetes. Med. Lett. Drugs Ther. 52, 25-27.
-
(2010)
Med. Lett. Drugs Ther.
, vol.52
, pp. 25-27
-
-
-
10
-
-
84871286519
-
Restructuring G-protein- coupled receptor activation
-
Audet, M., and Bouvier, M. (2012). Restructuring G-protein- coupled receptor activation. Cell 151, 14-23.
-
(2012)
Cell
, vol.151
, pp. 14-23
-
-
Audet, M.1
Bouvier, M.2
-
11
-
-
34248223285
-
Biology of incretins: GLP-1 and GIP
-
Baggio, L. L., and Drucker, D. J. (2007). Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157.
-
(2007)
Gastroenterology
, vol.132
, pp. 2131-2157
-
-
Baggio, L.L.1
Drucker, D.J.2
-
12
-
-
33847373003
-
Early discontinuation of tamoxifen: a lesson for oncologists
-
Barron, T. I., Connolly, R., Bennett, K., Feely, J., and Kennedy, M. J. (2007). Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 109, 832-839.
-
(2007)
Cancer
, vol.109
, pp. 832-839
-
-
Barron, T.I.1
Connolly, R.2
Bennett, K.3
Feely, J.4
Kennedy, M.J.5
-
13
-
-
0034626064
-
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer
-
Bergman, L., Beelen, M. L., Gallee, M. P., Hollema, H., Benraadt, J., and van Leeuwen, F. E. (2000). Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 356, 881-887.
-
(2000)
Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet
, vol.356
, pp. 881-887
-
-
Bergman, L.1
Beelen, M.L.2
Gallee, M.P.3
Hollema, H.4
Benraadt, J.5
van Leeuwen, F.E.6
-
14
-
-
0033530255
-
Tamoxifen therapy for breast cancer and endometrial cancer risk
-
Bernstein, L., Deapen, D., Cerhan, J. R., Schwartz, S. M., Liff, J., McGann-Maloney, E., et al. (1999). Tamoxifen therapy for breast cancer and endometrial cancer risk. J. Natl. Cancer Inst. 91, 1654-1662.
-
(1999)
J. Natl. Cancer Inst.
, vol.91
, pp. 1654-1662
-
-
Bernstein, L.1
Deapen, D.2
Cerhan, J.R.3
Schwartz, S.M.4
Liff, J.5
McGann-Maloney, E.6
-
15
-
-
9644254427
-
Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo
-
Bierkamp, C., Bonhoure, S., Mathieu, A., Clerc, P., Fourmy, D., Pradayrol, L., et al. (2004). Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo. Am. J. Pathol. 165, 2135-2145.
-
(2004)
Am. J. Pathol.
, vol.165
, pp. 2135-2145
-
-
Bierkamp, C.1
Bonhoure, S.2
Mathieu, A.3
Clerc, P.4
Fourmy, D.5
Pradayrol, L.6
-
16
-
-
0037064132
-
Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations
-
Bisello, A., Chorev, M., Rosenblatt, M., Monticelli, L., Mierke, D. F., and Ferrari, S. L. (2002). Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J. Biol. Chem. 277, 38524-38530.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 38524-38530
-
-
Bisello, A.1
Chorev, M.2
Rosenblatt, M.3
Monticelli, L.4
Mierke, D.F.5
Ferrari, S.L.6
-
17
-
-
77950228684
-
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation
-
Bjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., et al. (2010). Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology 151, 1473-1486.
-
(2010)
Endocrinology
, vol.151
, pp. 1473-1486
-
-
Bjerre Knudsen, L.1
Madsen, L.W.2
Andersen, S.3
Almholt, K.4
de Boer, A.S.5
Drucker, D.J.6
-
18
-
-
51049084866
-
Residual risk of breast cancer recurrence 5 years after adjuvant therapy
-
Brewster, A. M., Hortobagyi, G. N., Broglio, K. R., Kau, S. W., Santa-Maria, C. A., Arun, B., et al. (2008). Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J. Natl. Cancer Inst. 100, 1179-1183.
-
(2008)
J. Natl. Cancer Inst.
, vol.100
, pp. 1179-1183
-
-
Brewster, A.M.1
Hortobagyi, G.N.2
Broglio, K.R.3
Kau, S.W.4
Santa-Maria, C.A.5
Arun, B.6
-
19
-
-
2542479899
-
Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
-
Brubaker, P. L., and Drucker, D. J. (2004). Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145, 2653-2659.
-
(2004)
Endocrinology
, vol.145
, pp. 2653-2659
-
-
Brubaker, P.L.1
Drucker, D.J.2
-
20
-
-
84865020296
-
Effect of exendin (exenatide)-GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model
-
Bulchandani, D., Nachnani, J. S., Herndon, B., Molteni, A., Pathan, M. H., Quinn, T., et al. (2012). Effect of exendin (exenatide)-GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model. Eur. J. Pharmacol. 691, 292-296.
-
(2012)
Eur. J. Pharmacol.
, vol.691
, pp. 292-296
-
-
Bulchandani, D.1
Nachnani, J.S.2
Herndon, B.3
Molteni, A.4
Pathan, M.H.5
Quinn, T.6
-
21
-
-
84867565635
-
Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30
-
doi:10.1371/journal.pone.0046861
-
Burai, R., Ramesh, C., Nayak, T. K., Dennis, M. K., Bryant, B. K., Prossnitz, E. R., et al. (2012). Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30. PLoS ONE 7:e46861. doi:10.1371/journal.pone.0046861
-
(2012)
PLoS ONE
, vol.7
-
-
Burai, R.1
Ramesh, C.2
Nayak, T.K.3
Dennis, M.K.4
Bryant, B.K.5
Prossnitz, E.R.6
-
22
-
-
84859267187
-
G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors
-
Burch, M. L., Osman, N., Getachew, R., Al-Aryahi, S., Poronnik, P., Zheng, W., et al. (2012). G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors. Int. J. Biochem. Cell Biol. 44, 722-727.
-
(2012)
Int. J. Biochem. Cell Biol.
, vol.44
, pp. 722-727
-
-
Burch, M.L.1
Osman, N.2
Getachew, R.3
Al-Aryahi, S.4
Poronnik, P.5
Zheng, W.6
-
23
-
-
67649666737
-
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
-
Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., et al. (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 374, 39-47.
-
(2009)
Lancet
, vol.374
, pp. 39-47
-
-
Buse, J.B.1
Rosenstock, J.2
Sesti, G.3
Schmidt, W.E.4
Montanya, E.5
Brett, J.H.6
-
24
-
-
84856759440
-
Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes
-
Busnelli, M., Sauliere, A., Manning, M., Bouvier, M., Gales, C., and Chini, B. (2012). Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J. Biol. Chem. 287, 3617-3629.
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 3617-3629
-
-
Busnelli, M.1
Sauliere, A.2
Manning, M.3
Bouvier, M.4
Gales, C.5
Chini, B.6
-
25
-
-
0037221488
-
Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor
-
Buteau, J., Foisy, S., Joly, E., and Prentki, M. (2003). Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52, 124-132.
-
(2003)
Diabetes
, vol.52
, pp. 124-132
-
-
Buteau, J.1
Foisy, S.2
Joly, E.3
Prentki, M.4
-
26
-
-
0031282001
-
Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer
-
Carmeci, C., Thompson, D. A., Ring, H. Z., Francke, U., and Weigel, R. J. (1997). Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45, 607-617.
-
(1997)
Genomics
, vol.45
, pp. 607-617
-
-
Carmeci, C.1
Thompson, D.A.2
Ring, H.Z.3
Francke, U.4
Weigel, R.J.5
-
27
-
-
33746600263
-
Estrogen receptor target gene: an evolving concept
-
Carroll, J. S., and Brown, M. (2006). Estrogen receptor target gene: an evolving concept. Mol. Endocrinol. 20, 1707-1714.
-
(2006)
Mol. Endocrinol.
, vol.20
, pp. 1707-1714
-
-
Carroll, J.S.1
Brown, M.2
-
28
-
-
33746519903
-
Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells
-
Cayrol, C., Clerc, P., Bertrand, C., Gigoux, V., Portolan, G., Fourmy, D., et al. (2006). Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells. Oncogene 25, 4421-4428.
-
(2006)
Oncogene
, vol.25
, pp. 4421-4428
-
-
Cayrol, C.1
Clerc, P.2
Bertrand, C.3
Gigoux, V.4
Portolan, G.5
Fourmy, D.6
-
29
-
-
73549093367
-
Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways
-
Cescato, R., Loesch, K. A., Waser, B., Macke, H. R., Rivier, J. E., Reubi, J. C., et al. (2010). Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways. Mol. Endocrinol. 24, 240-249.
-
(2010)
Mol. Endocrinol.
, vol.24
, pp. 240-249
-
-
Cescato, R.1
Loesch, K.A.2
Waser, B.3
Macke, H.R.4
Rivier, J.E.5
Reubi, J.C.6
-
30
-
-
77955711650
-
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest
-
Chan, Q. K., Lam, H. M., Ng, C. F., Lee, A. Y., Chan, E. S., Ng, H. K., et al. (2010). Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ. 17, 1511-1523.
-
(2010)
Cell Death Differ.
, vol.17
, pp. 1511-1523
-
-
Chan, Q.K.1
Lam, H.M.2
Ng, C.F.3
Lee, A.Y.4
Chan, E.S.5
Ng, H.K.6
-
31
-
-
0038353630
-
The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose
-
Chang, A. M., Jakobsen, G., Sturis, J., Smith, M. J., Bloem, C. J., An, B., et al. (2003). The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose. Diabetes 52, 1786-1791.
-
(2003)
Diabetes
, vol.52
, pp. 1786-1791
-
-
Chang, A.M.1
Jakobsen, G.2
Sturis, J.3
Smith, M.J.4
Bloem, C.J.5
An, B.6
-
32
-
-
57349130733
-
Estrogen and its receptors in cancer
-
Chen, G. G., Zeng, Q., and Tse, G. M. (2008). Estrogen and its receptors in cancer. Med. Res. Rev. 28, 954-974.
-
(2008)
Med. Res. Rev.
, vol.28
, pp. 954-974
-
-
Chen, G.G.1
Zeng, Q.2
Tse, G.M.3
-
33
-
-
79959870180
-
Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus
-
Cheng, S. B., Graeber, C. T., Quinn, J. A., and Filardo, E. J. (2011). Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids 76, 892-896.
-
(2011)
Steroids
, vol.76
, pp. 892-896
-
-
Cheng, S.B.1
Graeber, C.T.2
Quinn, J.A.3
Filardo, E.J.4
-
34
-
-
80055119745
-
Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30
-
Chevalier, N., Bouskine, A., and Fenichel, P. (2012). Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int. J. Cancer 130, 241-242.
-
(2012)
Int. J. Cancer
, vol.130
, pp. 241-242
-
-
Chevalier, N.1
Bouskine, A.2
Fenichel, P.3
-
35
-
-
53749085064
-
Incretin-based therapies in type 2 diabetes mellitus
-
Chia, C. W., and Egan, J. M. (2008). Incretin-based therapies in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 93, 3703-3716.
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 3703-3716
-
-
Chia, C.W.1
Egan, J.M.2
-
36
-
-
78649353120
-
Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a review
-
Christ, E., Wild, D., and Reubi, J. C. (2010). Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a review. Endocrinol. Metab. Clin. North Am. 39, 791-800.
-
(2010)
Endocrinol. Metab. Clin. North Am.
, vol.39
, pp. 791-800
-
-
Christ, E.1
Wild, D.2
Reubi, J.C.3
-
37
-
-
80053357815
-
Conformational changes in the G protein Gs induced by the beta2 adrenergic receptor
-
Chung, K. Y., Rasmussen, S. G., Liu, T., Li, S., DeVree, B. T., Chae, P. S., et al. (2011). Conformational changes in the G protein Gs induced by the beta2 adrenergic receptor. Nature 477, 611-615.
-
(2011)
Nature
, vol.477
, pp. 611-615
-
-
Chung, K.Y.1
Rasmussen, S.G.2
Liu, T.3
Li, S.4
DeVree, B.T.5
Chae, P.S.6
-
38
-
-
0034992614
-
Molecular and pharmacological aspects of antiestrogen resistance
-
Clarke, R., Skaar, T. C., Bouker, K. B., Davis, N., Lee, Y. R., Welch, J. N., et al. (2001). Molecular and pharmacological aspects of antiestrogen resistance. J. Steroid Biochem. Mol. Biol. 76, 71-84.
-
(2001)
J. Steroid Biochem. Mol. Biol.
, vol.76
, pp. 71-84
-
-
Clarke, R.1
Skaar, T.C.2
Bouker, K.B.3
Davis, N.4
Lee, Y.R.5
Welch, J.N.6
-
39
-
-
0036161385
-
Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia
-
Clerc, P., Leung-Theung-Long, S., Wang, T. C., Dockray, G. J., Bouisson, M., Delisle, M. B., et al. (2002a). Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia. Gastroenterology 122, 428-437.
-
(2002)
Gastroenterology
, vol.122
, pp. 428-437
-
-
Clerc, P.1
Leung-Theung-Long, S.2
Wang, T.C.3
Dockray, G.J.4
Bouisson, M.5
Delisle, M.B.6
-
40
-
-
0036971273
-
Transgenic mice expressing cholecystokinin 2 receptors in the pancreas
-
Clerc, P., Saillan-Barreau, C., Desbois, C., Pradayrol, L., Fourmy, D., and Dufresne, M. (2002b). Transgenic mice expressing cholecystokinin 2 receptors in the pancreas. Pharmacol. Toxicol. 91, 321-326.
-
(2002)
Pharmacol. Toxicol.
, vol.91
, pp. 321-326
-
-
Clerc, P.1
Saillan-Barreau, C.2
Desbois, C.3
Pradayrol, L.4
Fourmy, D.5
Dufresne, M.6
-
41
-
-
77956191559
-
The vasoactive intestinal peptide-receptor system is involved in human glioblastoma cell migration
-
Cochaud, S., Chevrier, L., Meunier, A. C., Brillet, T., Chadeneau, C., and Muller, J. M. (2010). The vasoactive intestinal peptide-receptor system is involved in human glioblastoma cell migration. Neuropeptides 44, 373-383.
-
(2010)
Neuropeptides
, vol.44
, pp. 373-383
-
-
Cochaud, S.1
Chevrier, L.2
Meunier, A.C.3
Brillet, T.4
Chadeneau, C.5
Muller, J.M.6
-
42
-
-
33846964878
-
Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules
-
Costante, G., Meringolo, D., Durante, C., Bianchi, D., Nocera, M., Tumino, S., et al. (2007). Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J. Clin. Endocrinol. Metab. 92, 450-455.
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, pp. 450-455
-
-
Costante, G.1
Meringolo, D.2
Durante, C.3
Bianchi, D.4
Nocera, M.5
Tumino, S.6
-
43
-
-
42949112670
-
Exenatide and rare adverse events
-
discussion 1971-1972
-
Cure, P., Pileggi, A., and Alejandro, R. (2008). Exenatide and rare adverse events. N. Engl. J. Med. 358, 1969-1970; discussion 1971-1972.
-
(2008)
N. Engl. J. Med.
, vol.358
, pp. 1969-1970
-
-
Cure, P.1
Pileggi, A.2
Alejandro, R.3
-
44
-
-
33646354927
-
Exenatide (exendin-4)-induced pancreatitis: a case report
-
Denker, P. S., and Dimarco, P. E. (2006). Exenatide (exendin-4)-induced pancreatitis: a case report. Diabetes Care 29, 471.
-
(2006)
Diabetes Care
, vol.29
, pp. 471
-
-
Denker, P.S.1
Dimarco, P.E.2
-
45
-
-
67349140294
-
In vivo effects of a GPR30 antagonist
-
Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., et al. (2009). In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 5, 421-427.
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 421-427
-
-
Dennis, M.K.1
Burai, R.2
Ramesh, C.3
Petrie, W.K.4
Alcon, S.N.5
Nayak, T.K.6
-
46
-
-
81255160989
-
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
-
Dennis, M. K., Field, A. S., Burai, R., Ramesh, C., Petrie, W. K., Bologa, C. G., et al. (2011). Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J. Steroid Biochem. Mol. Biol. 127, 358-366.
-
(2011)
J. Steroid Biochem. Mol. Biol.
, vol.127
, pp. 358-366
-
-
Dennis, M.K.1
Field, A.S.2
Burai, R.3
Ramesh, C.4
Petrie, W.K.5
Bologa, C.G.6
-
47
-
-
33644638521
-
Estrogen receptors and human disease
-
Deroo, B. J., and Korach, K. S. (2006). Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570.
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 561-570
-
-
Deroo, B.J.1
Korach, K.S.2
-
48
-
-
33847617011
-
Mechanisms of action of glucagon-like peptide 1 in the pancreas
-
Doyle, M. E., and Egan, J. M. (2007). Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol. Ther. 113, 546-593.
-
(2007)
Pharmacol. Ther.
, vol.113
, pp. 546-593
-
-
Doyle, M.E.1
Egan, J.M.2
-
49
-
-
0037312818
-
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis
-
Drucker, D. J. (2003). Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol. Endocrinol. 17, 161-171.
-
(2003)
Mol. Endocrinol.
, vol.17
, pp. 161-171
-
-
Drucker, D.J.1
-
50
-
-
33644618433
-
The biology of incretin hormones
-
Drucker, D. J. (2006). The biology of incretin hormones. Cell Metab. 3, 153-165.
-
(2006)
Cell Metab.
, vol.3
, pp. 153-165
-
-
Drucker, D.J.1
-
51
-
-
84862822293
-
The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells
-
Du, G. Q., Zhou, L., Chen, X. Y., Wan, X. P., and He, Y. Y. (2012a). The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. Biochem. Biophys. Res. Commun. 420, 343-349.
-
(2012)
Biochem. Biophys. Res. Commun.
, vol.420
, pp. 343-349
-
-
Du, G.Q.1
Zhou, L.2
Chen, X.Y.3
Wan, X.P.4
He, Y.Y.5
-
52
-
-
84860752363
-
Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling
-
Du, N., Feng, J., Hu, L. J., Sun, X., Sun, H. B., Zhao, Y., et al. (2012b). Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol. Rep. 27, 1893-1903.
-
(2012)
Oncol. Rep.
, vol.27
, pp. 1893-1903
-
-
Du, N.1
Feng, J.2
Hu, L.J.3
Sun, X.4
Sun, H.B.5
Zhao, Y.6
-
53
-
-
33644841711
-
Cholecystokinin and gastrin receptors
-
Dufresne, M., Seva, C., and Fourmy, D. (2006). Cholecystokinin and gastrin receptors. Physiol. Rev. 86, 805-847.
-
(2006)
Physiol. Rev.
, vol.86
, pp. 805-847
-
-
Dufresne, M.1
Seva, C.2
Fourmy, D.3
-
54
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687-1717.
-
(2005)
Lancet
, vol.365
, pp. 1687-1717
-
-
-
55
-
-
15744393640
-
Regulation of signal transduction pathways by estrogen and progesterone
-
Edwards, D. P. (2005). Regulation of signal transduction pathways by estrogen and progesterone. Annu. Rev. Physiol. 67, 335-376.
-
(2005)
Annu. Rev. Physiol.
, vol.67
, pp. 335-376
-
-
Edwards, D.P.1
-
56
-
-
79959559653
-
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
-
Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., and Butler, P. C. (2011). Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 141, 150-156.
-
(2011)
Gastroenterology
, vol.141
, pp. 150-156
-
-
Elashoff, M.1
Matveyenko, A.V.2
Gier, B.3
Elashoff, R.4
Butler, P.C.5
-
57
-
-
10744223544
-
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders
-
Elisei, R., Bottici, V., Luchetti, F., Di Coscio, G., Romei, C., Grasso, L., et al. (2004). Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab. 89, 163-168.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 163-168
-
-
Elisei, R.1
Bottici, V.2
Luchetti, F.3
Di Coscio, G.4
Romei, C.5
Grasso, L.6
-
58
-
-
84884186582
-
-
European Medicines Agency (EMA) [accessed September]
-
European Medicines Agency (EMA). (2006). Assessment Report for Byetta. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000698/WC500051842.pdf [accessed September 27, 2011].
-
(2006)
Assessment Report for Byetta. Available at
, vol.27
-
-
-
59
-
-
84884171865
-
-
European Medicines Agency (EMA) [accessed September]
-
European Medicines Agency (EMA). (2009). Assessment report for Victoza. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016. pdf [accessed September 27, 2011].
-
(2009)
Assessment report for Victoza. Available at
, vol.27
, pp. 2011
-
-
-
60
-
-
84884182744
-
-
European Medicines Agency (EMA)[accessed September]
-
European Medicines Agency (EMA). (2011). Assessment Report for By-Dureon. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002020/WC500108239.pdf [accessed September 27, 2011].
-
(2011)
Assessment Report for By-Dureon. Available at
, vol.27
, pp. 2011
-
-
-
61
-
-
78649883325
-
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis
-
Feng, S., Agoulnik, I. U., Truong, A., Li, Z., Creighton, C. J., Kaftanovskaya, E. M., et al. (2010). Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. Endocr. Relat. Cancer 17, 1021-1033.
-
(2010)
Endocr. Relat. Cancer
, vol.17
, pp. 1021-1033
-
-
Feng, S.1
Agoulnik, I.U.2
Truong, A.3
Li, Z.4
Creighton, C.J.5
Kaftanovskaya, E.M.6
-
62
-
-
77957919319
-
Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1
-
Fernandez-Martinez, A. B., Bajo, A. M., Isabel Arenas, M., Sanchez-Chapado, M., Prieto, J. C., and Carmena, M. J. (2010). Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1. Cancer Lett. 299, 11-21.
-
(2010)
Cancer Lett.
, vol.299
, pp. 11-21
-
-
Fernandez-Martinez, A.B.1
Bajo, A.M.2
Isabel Arenas, M.3
Sanchez-Chapado, M.4
Prieto, J.C.5
Carmena, M.J.6
-
63
-
-
33751272253
-
Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression
-
Filardo, E. J., Graeber, C. T., Quinn, J. A., Resnick, M. B., Giri, D., DeLellis, R. A., et al. (2006). Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin. Cancer Res. 12, 6359-6366.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 6359-6366
-
-
Filardo, E.J.1
Graeber, C.T.2
Quinn, J.A.3
Resnick, M.B.4
Giri, D.5
DeLellis, R.A.6
-
64
-
-
0033780783
-
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
-
Filardo, E. J., Quinn, J. A., Bland, K. I., and Frackelton, A. R. Jr. (2000). Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14, 1649-1660.
-
(2000)
Mol. Endocrinol.
, vol.14
, pp. 1649-1660
-
-
Filardo, E.J.1
Quinn, J.A.2
Bland, K.I.3
Frackelton, A.R.Jr.4
-
65
-
-
79952762504
-
GPR30 is overexpressed in post-puberal testicular germ cell tumors
-
Franco, R., Boscia, F., Gigantino, V., Marra, L., Esposito, F., Ferrara, D., et al. (2011). GPR30 is overexpressed in post-puberal testicular germ cell tumors. Cancer Biol. Ther. 11, 609-613.
-
(2011)
Cancer Biol. Ther.
, vol.11
, pp. 609-613
-
-
Franco, R.1
Boscia, F.2
Gigantino, V.3
Marra, L.4
Esposito, F.5
Ferrara, D.6
-
66
-
-
78650186098
-
Expression and in vitro functions of the ghrelin axis in endometrial cancer
-
Fung, J. N., Seim, I., Wang, D., Obermair, A., Chopin, L. K., and Chen, C. (2010). Expression and in vitro functions of the ghrelin axis in endometrial cancer. Horm. Cancer 1, 245-255.
-
(2010)
Horm. Cancer
, vol.1
, pp. 245-255
-
-
Fung, J.N.1
Seim, I.2
Wang, D.3
Obermair, A.4
Chopin, L.K.5
Chen, C.6
-
67
-
-
73949084919
-
A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation
-
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., et al. (2009). A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci. Transl. Med. 1, 1ra1.
-
(2009)
Sci. Transl. Med.
, vol.1
-
-
Gesty-Palmer, D.1
Flannery, P.2
Yuan, L.3
Corsino, L.4
Spurney, R.5
Lefkowitz, R.J.6
-
68
-
-
79961236811
-
Biasing the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?
-
Gesty-Palmer, D., and Luttrell, L. M. (2011). "Biasing" the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass? Br. J. Pharmacol. 164, 59-67.
-
(2011)
Br. J. Pharmacol.
, vol.164
, pp. 59-67
-
-
Gesty-Palmer, D.1
Luttrell, L.M.2
-
69
-
-
70350513347
-
Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras
-
Gidekel Friedlander, S. Y., Chu, G. C., Snyder, E. L., Girnius, N., Dibelius, G., Crowley, D., et al. (2009). Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 16, 379-389.
-
(2009)
Cancer Cell
, vol.16
, pp. 379-389
-
-
Gidekel Friedlander, S.Y.1
Chu, G.C.2
Snyder, E.L.3
Girnius, N.4
Dibelius, G.5
Crowley, D.6
-
70
-
-
84860567470
-
Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
-
Gier, B., Matveyenko, A. V., Kirakossian, D., Dawson, D., Dry, S. M., and Butler, P. C. (2012a). Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model. Diabetes 61, 1250-1262.
-
(2012)
Diabetes
, vol.61
, pp. 1250-1262
-
-
Gier, B.1
Matveyenko, A.V.2
Kirakossian, D.3
Dawson, D.4
Dry, S.M.5
Butler, P.C.6
-
71
-
-
84855489636
-
Glucagon like peptide-1 receptor expression in the human thyroid gland
-
Gier, B., Butler, P. C., Lai, C. K., Kirakossian, D., DeNicola, M. M., and Yeh, M. W. (2012b). Glucagon like peptide-1 receptor expression in the human thyroid gland. J. Clin. Endocrinol. Metab. 97, 121-131.
-
(2012)
J. Clin. Endocrinol. Metab.
, vol.97
, pp. 121-131
-
-
Gier, B.1
Butler, P.C.2
Lai, C.K.3
Kirakossian, D.4
DeNicola, M.M.5
Yeh, M.W.6
-
72
-
-
38349022253
-
Reg genes are CCK2 receptor targets in ElasCCK2 mice pancreas
-
Gigoux, V., Clerc, P., Sanchez, D., Coll, M. G., Corominola, H., Leung-Theung-Long, S., et al. (2008). Reg genes are CCK2 receptor targets in ElasCCK2 mice pancreas. Regul. Pept. 146, 88-98.
-
(2008)
Regul. Pept.
, vol.146
, pp. 88-98
-
-
Gigoux, V.1
Clerc, P.2
Sanchez, D.3
Coll, M.G.4
Corominola, H.5
Leung-Theung-Long, S.6
-
73
-
-
77955517441
-
Diabetes and cancer: a consensus report
-
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., et al. (2010). Diabetes and cancer: a consensus report. Diabetes Care 33, 1674-1685.
-
(2010)
Diabetes Care
, vol.33
, pp. 1674-1685
-
-
Giovannucci, E.1
Harlan, D.M.2
Archer, M.C.3
Bergenstal, R.M.4
Gapstur, S.M.5
Habel, L.A.6
-
74
-
-
77955016889
-
Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes
-
Girman, C. J., Kou, T. D., Cai, B., Alexander, C. M., O'Neill, E. A., Williams-Herman, D. E., et al. (2010). Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes. Metab. 12, 766-771.
-
(2010)
Diabetes Obes. Metab.
, vol.12
, pp. 766-771
-
-
Girman, C.J.1
Kou, T.D.2
Cai, B.3
Alexander, C.M.4
O'Neill, E.A.5
Williams-Herman, D.E.6
-
75
-
-
0027184119
-
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
-
Goke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., et al. (1993). Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J. Biol. Chem. 268, 19650-19655.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 19650-19655
-
-
Goke, R.1
Fehmann, H.C.2
Linn, T.3
Schmidt, H.4
Krause, M.5
Eng, J.6
-
76
-
-
0035687010
-
The effect of SERMs on the endometrium
-
Goldstein, S. R. (2001). The effect of SERMs on the endometrium. Ann. N. Y. Acad. Sci. 949, 237-242.
-
(2001)
Ann. N. Y. Acad. Sci.
, vol.949
, pp. 237-242
-
-
Goldstein, S.R.1
-
77
-
-
0023915865
-
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse
-
Gottardis, M. M., Robinson, S. P., Satyaswaroop, P. G., and Jordan, V. C. (1988). Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res. 48, 812-815.
-
(1988)
Cancer Res.
, vol.48
, pp. 812-815
-
-
Gottardis, M.M.1
Robinson, S.P.2
Satyaswaroop, P.G.3
Jordan, V.C.4
-
78
-
-
33646788425
-
Exocrine meets endocrine: pancreatic stone protein and regenerating protein-two sides of the same coin
-
Graf, R., Schiesser, M., Reding, T., Appenzeller, P., Sun, L. K., Fortunato, F., et al. (2006). Exocrine meets endocrine: pancreatic stone protein and regenerating protein-two sides of the same coin. J. Surg. Res. 133, 113-120.
-
(2006)
J. Surg. Res.
, vol.133
, pp. 113-120
-
-
Graf, R.1
Schiesser, M.2
Reding, T.3
Appenzeller, P.4
Sun, L.K.5
Fortunato, F.6
-
79
-
-
34250376066
-
Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies
-
Granier, S., Kim, S., Shafer, A. M., Ratnala, V. R., Fung, J. J., Zare, R. N., et al. (2007). Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies. J. Biol. Chem. 282, 13895-13905.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 13895-13905
-
-
Granier, S.1
Kim, S.2
Shafer, A.M.3
Ratnala, V.R.4
Fung, J.J.5
Zare, R.N.6
-
80
-
-
68849105055
-
Inflammation and pancreatic cancer: an evidence-based review
-
Greer, J. B., and Whitcomb, D. C. (2009). Inflammation and pancreatic cancer: an evidence-based review. Curr. Opin. Pharmacol. 9, 411-418.
-
(2009)
Curr. Opin. Pharmacol.
, vol.9
, pp. 411-418
-
-
Greer, J.B.1
Whitcomb, D.C.2
-
81
-
-
78651306525
-
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells
-
Grieco, P., Franco, R., Bozzuto, G., Toccacieli, L., Sgambato, A., Marra, M., et al. (2011). Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. J. Cell. Biochem. 112, 341-353.
-
(2011)
J. Cell. Biochem.
, vol.112
, pp. 341-353
-
-
Grieco, P.1
Franco, R.2
Bozzuto, G.3
Toccacieli, L.4
Sgambato, A.5
Marra, M.6
-
82
-
-
33745006404
-
Physiology of somatostatin receptors
-
Guillermet-Guibert, J., Lahlou, H., Cordelier, P., Bousquet, C., Pyronnet, S., and Susini, C. (2005). Physiology of somatostatin receptors. J. Endocrinol. Invest. 28, 5-9.
-
(2005)
J. Endocrinol. Invest.
, vol.28
, pp. 5-9
-
-
Guillermet-Guibert, J.1
Lahlou, H.2
Cordelier, P.3
Bousquet, C.4
Pyronnet, S.5
Susini, C.6
-
83
-
-
84866485226
-
Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation
-
Hafiz, S., Dennis, J. C., Schwartz, D., Judd, R., Tao, Y. X., Khazal, K., et al. (2012). Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation. Int. J. Oncol. 41, 1373-1380.
-
(2012)
Int. J. Oncol.
, vol.41
, pp. 1373-1380
-
-
Hafiz, S.1
Dennis, J.C.2
Schwartz, D.3
Judd, R.4
Tao, Y.X.5
Khazal, K.6
-
84
-
-
37349081370
-
Extranuclear steroid receptors: nature and actions
-
Hammes, S. R., and Levin, E. R. (2007). Extranuclear steroid receptors: nature and actions. Endocr. Rev. 28, 726-741.
-
(2007)
Endocr. Rev.
, vol.28
, pp. 726-741
-
-
Hammes, S.R.1
Levin, E.R.2
-
85
-
-
84868585481
-
Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery
-
Harikumar, K. G., Wootten, D., Pinon, D. I., Koole, C., Ball, A. M., Furness, S. G., et al. (2012). Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery. Proc. Natl. Acad. Sci. U.S.A. 109, 18607-18612.
-
(2012)
Proc. Natl. Acad. Sci. U.S.A.
, vol.109
, pp. 18607-18612
-
-
Harikumar, K.G.1
Wootten, D.2
Pinon, D.I.3
Koole, C.4
Ball, A.M.5
Furness, S.G.6
-
86
-
-
67649888455
-
Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway
-
He, Y. Y., Cai, B., Yang, Y. X., Liu, X. L., and Wan, X. P. (2009). Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci. 100, 1051-1061.
-
(2009)
Cancer Sci.
, vol.100
, pp. 1051-1061
-
-
He, Y.Y.1
Cai, B.2
Yang, Y.X.3
Liu, X.L.4
Wan, X.P.5
-
87
-
-
84862303608
-
Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2
-
He, Y. Y., Du, G. Q., Cai, B., Yan, Q., Zhou, L., Chen, X. Y., et al. (2012). Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2. J. Cancer Res. Clin. Oncol. 138, 775-783.
-
(2012)
J. Cancer Res. Clin. Oncol.
, vol.138
, pp. 775-783
-
-
He, Y.Y.1
Du, G.Q.2
Cai, B.3
Yan, Q.4
Zhou, L.5
Chen, X.Y.6
-
88
-
-
79952284556
-
GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide
-
Hegedus, L., Moses, A. C., Zdravkovic, M., Le Thi, T., and Daniels, G. H. (2011). GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide. J. Clin. Endocrinol. Metab. 96, 853-860.
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.96
, pp. 853-860
-
-
Hegedus, L.1
Moses, A.C.2
Zdravkovic, M.3
Le Thi, T.4
Daniels, G.H.5
-
89
-
-
65649135116
-
Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells
-
Henic, E., Noskova, V., Hoyer-Hansen, G., Hansson, S., and Casslen, B. (2009). Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells. Int. J. Gynecol. Cancer 19, 214-222.
-
(2009)
Int. J. Gynecol. Cancer
, vol.19
, pp. 214-222
-
-
Henic, E.1
Noskova, V.2
Hoyer-Hansen, G.3
Hansson, S.4
Casslen, B.5
-
90
-
-
49849101934
-
Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution
-
Hernandez-Munoz, I., Skoudy, A., Real, F. X., and Navarro, P. (2008). Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution. Pancreatology 8, 462-469.
-
(2008)
Pancreatology
, vol.8
, pp. 462-469
-
-
Hernandez-Munoz, I.1
Skoudy, A.2
Real, F.X.3
Navarro, P.4
-
91
-
-
21344454577
-
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use
-
Hodsman, A. B., Bauer, D. C., Dempster, D. W., Dian, L., Hanley, D. A., Harris, S. T., et al. (2005). Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr. Rev. 26, 688-703.
-
(2005)
Endocr. Rev.
, vol.26
, pp. 688-703
-
-
Hodsman, A.B.1
Bauer, D.C.2
Dempster, D.W.3
Dian, L.4
Hanley, D.A.5
Harris, S.T.6
-
92
-
-
35748957503
-
The physiology of glucagon-like peptide 1
-
Holst, J. J. (2007). The physiology of glucagon-like peptide 1. Physiol. Rev. 87, 1409-1439.
-
(2007)
Physiol. Rev.
, vol.87
, pp. 1409-1439
-
-
Holst, J.J.1
-
93
-
-
0030876081
-
The pathogenesis of NIDDM involves a defective expression of the GIP receptor
-
Holst, J. J., Gromada, J., and Nauck, M. A. (1997). The pathogenesis of NIDDM involves a defective expression of the GIP receptor. Diabetologia 40, 984-986.
-
(1997)
Diabetologia
, vol.40
, pp. 984-986
-
-
Holst, J.J.1
Gromada, J.2
Nauck, M.A.3
-
94
-
-
0347990624
-
Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell
-
Holz, G. G. (2004). Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 53, 5-13.
-
(2004)
Diabetes
, vol.53
, pp. 5-13
-
-
Holz, G.G.1
-
96
-
-
0343632386
-
Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat
-
Horsch, D., Goke, R., Eissele, R., Michel, B., and Goke, B. (1997). Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat. Pancreas 14, 290-294.
-
(1997)
Pancreas
, vol.14
, pp. 290-294
-
-
Horsch, D.1
Goke, R.2
Eissele, R.3
Michel, B.4
Goke, B.5
-
97
-
-
79959770197
-
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer
-
Ignatov, A., Ignatov, T., Weissenborn, C., Eggemann, H., Bischoff, J., Semczuk, A., et al. (2011). G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer. Breast Cancer Res. Treat. 128, 457-466.
-
(2011)
Breast Cancer Res. Treat.
, vol.128
, pp. 457-466
-
-
Ignatov, A.1
Ignatov, T.2
Weissenborn, C.3
Eggemann, H.4
Bischoff, J.5
Semczuk, A.6
-
98
-
-
79952119039
-
Role of GPR30 in endometrial pathology after tamoxifen for breast cancer
-
Ignatov, T., Eggemann, H., Semczuk, A., Smith, B., Bischoff, J., Roessner, A., et al. (2010a). Role of GPR30 in endometrial pathology after tamoxifen for breast cancer. Am. J. Obstet. Gynecol. 203, e9-e16.
-
(2010)
Am. J. Obstet. Gynecol.
, vol.203
-
-
Ignatov, T.1
Eggemann, H.2
Semczuk, A.3
Smith, B.4
Bischoff, J.5
Roessner, A.6
-
99
-
-
77955771545
-
Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
-
Ignatov, A., Ignatov, T., Roessner, A., Costa, S. D., and Kalinski, T. (2010b). Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res. Treat. 123, 87-96.
-
(2010)
Breast Cancer Res. Treat.
, vol.123
, pp. 87-96
-
-
Ignatov, A.1
Ignatov, T.2
Roessner, A.3
Costa, S.D.4
Kalinski, T.5
-
100
-
-
0025892130
-
The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa)
-
Jamil, A., Croxtall, J. D., and White, J. O. (1991). The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa). J. Mol. Endocrinol. 6, 215-221.
-
(1991)
J. Mol. Endocrinol.
, vol.6
, pp. 215-221
-
-
Jamil, A.1
Croxtall, J.D.2
White, J.O.3
-
101
-
-
0036123510
-
Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
-
Jeffery, P. L., Herington, A. C., and Chopin, L. K. (2002). Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J. Endocrinol. 172, R7-R11.
-
(2002)
J. Endocrinol.
, vol.172
-
-
Jeffery, P.L.1
Herington, A.C.2
Chopin, L.K.3
-
102
-
-
28544446509
-
Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines
-
Jeffery, P. L., Murray, R. E., Yeh, A. H., McNamara, J. F., Duncan, R. P., Francis, G. D., et al. (2005). Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr. Relat. Cancer 12, 839-850.
-
(2005)
Endocr. Relat. Cancer
, vol.12
, pp. 839-850
-
-
Jeffery, P.L.1
Murray, R.E.2
Yeh, A.H.3
McNamara, J.F.4
Duncan, R.P.5
Francis, G.D.6
-
103
-
-
0033578005
-
G-protein-coupled receptor heterodimerization modulates receptor function
-
Jordan, B. A., and Devi, L. A. (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700.
-
(1999)
Nature
, vol.399
, pp. 697-700
-
-
Jordan, B.A.1
Devi, L.A.2
-
104
-
-
33947714587
-
SERMs: meeting the promise of multifunctional medicines
-
Jordan, V. C. (2007). SERMs: meeting the promise of multifunctional medicines. J. Natl. Cancer Inst. 99, 350-356.
-
(2007)
J. Natl. Cancer Inst.
, vol.99
, pp. 350-356
-
-
Jordan, V.C.1
-
105
-
-
0033304703
-
Tamoxifen, raloxifene, and the prevention of breast cancer
-
Jordan, V. C., and Morrow, M. (1999). Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr. Rev. 20, 253-278.
-
(1999)
Endocr. Rev.
, vol.20
, pp. 253-278
-
-
Jordan, V.C.1
Morrow, M.2
-
106
-
-
34250714898
-
Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s)
-
Jorgensen, R., Kubale, V., Vrecl, M., Schwartz, T. W., and Elling, C. E. (2007). Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s). J. Pharmacol. Exp. Ther. 322, 148-154.
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.322
, pp. 148-154
-
-
Jorgensen, R.1
Kubale, V.2
Vrecl, M.3
Schwartz, T.W.4
Elling, C.E.5
-
107
-
-
77951203576
-
Aromatase inhibitors versus tamoxifen as adjuvant hormonal therapy for oestrogen sensitive early breast cancer in post-menopausal women: meta-analyses of monotherapy, sequenced therapy and extended therapy
-
Josefsson, M. L., and Leinster, S. J. (2010). Aromatase inhibitors versus tamoxifen as adjuvant hormonal therapy for oestrogen sensitive early breast cancer in post-menopausal women: meta-analyses of monotherapy, sequenced therapy and extended therapy. Breast 19, 76-83.
-
(2010)
Breast
, vol.19
, pp. 76-83
-
-
Josefsson, M.L.1
Leinster, S.J.2
-
108
-
-
19644363283
-
Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between
-
Jura, N., Archer, H., and Bar-Sagi, D. (2005). Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between. Cell Res. 15, 72-77.
-
(2005)
Cell Res.
, vol.15
, pp. 72-77
-
-
Jura, N.1
Archer, H.2
Bar-Sagi, D.3
-
109
-
-
80052967337
-
Multiple ligand-specific conformations of the beta2-adrenergic receptor
-
Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., et al. (2011). Multiple ligand-specific conformations of the beta2-adrenergic receptor. Nat. Chem. Biol. 7, 692-700.
-
(2011)
Nat. Chem. Biol.
, vol.7
, pp. 692-700
-
-
Kahsai, A.W.1
Xiao, K.2
Rajagopal, S.3
Ahn, S.4
Shukla, A.K.5
Sun, J.6
-
110
-
-
0035824548
-
Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion
-
Kashima, Y., Miki, T., Shibasaki, T., Ozaki, N., Miyazaki, M., Yano, H., et al. (2001). Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J. Biol. Chem. 276, 46046-46053.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 46046-46053
-
-
Kashima, Y.1
Miki, T.2
Shibasaki, T.3
Ozaki, N.4
Miyazaki, M.5
Yano, H.6
-
111
-
-
61849136239
-
Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway
-
Ketterer, K., Kong, B., Frank, D., Giese, N. A., Bauer, A., Hoheisel, J., et al. (2009). Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway. Cancer Lett. 277, 72-81.
-
(2009)
Cancer Lett.
, vol.277
, pp. 72-81
-
-
Ketterer, K.1
Kong, B.2
Frank, D.3
Giese, N.A.4
Bauer, A.5
Hoheisel, J.6
-
112
-
-
55749084393
-
Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation
-
Kim, I. M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., et al. (2008). Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc. Natl. Acad. Sci. U.S.A. 105, 14555-14560.
-
(2008)
Proc. Natl. Acad. Sci. U.S.A.
, vol.105
, pp. 14555-14560
-
-
Kim, I.M.1
Tilley, D.G.2
Chen, J.3
Salazar, N.C.4
Whalen, E.J.5
Violin, J.D.6
-
113
-
-
57149102903
-
Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer
-
Kintzel, P. E., Chase, S. L., Schultz, L. M., and O'Rourke, T. J. (2008). Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. Pharmacotherapy 28, 1511-1522.
-
(2008)
Pharmacotherapy
, vol.28
, pp. 1511-1522
-
-
Kintzel, P.E.1
Chase, S.L.2
Schultz, L.M.3
O'Rourke, T.J.4
-
114
-
-
57349134539
-
17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30
-
Kleuser, B., Malek, D., Gust, R., Pertz, H. H., and Potteck, H. (2008). 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30. Mol. Pharmacol. 74, 1533-1543.
-
(2008)
Mol. Pharmacol.
, vol.74
, pp. 1533-1543
-
-
Kleuser, B.1
Malek, D.2
Gust, R.3
Pertz, H.H.4
Potteck, H.5
-
115
-
-
70349120958
-
Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice
-
Koehler, J. A., Baggio, L. L., Lamont, B. J., Ali, S., and Drucker, D. J. (2009). Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice. Diabetes 58, 2148-2161.
-
(2009)
Diabetes
, vol.58
, pp. 2148-2161
-
-
Koehler, J.A.1
Baggio, L.L.2
Lamont, B.J.3
Ali, S.4
Drucker, D.J.5
-
116
-
-
33745320855
-
Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells
-
Koehler, J. A., and Drucker, D. J. (2006). Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells. Diabetes 55, 1369-1379.
-
(2006)
Diabetes
, vol.55
, pp. 1369-1379
-
-
Koehler, J.A.1
Drucker, D.J.2
-
117
-
-
34250635159
-
GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting
-
Korner, M., Stockli, M., Waser, B., and Reubi, J. C. (2007). GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J. Nucl. Med. 48, 736-743.
-
(2007)
J. Nucl. Med.
, vol.48
, pp. 736-743
-
-
Korner, M.1
Stockli, M.2
Waser, B.3
Reubi, J.C.4
-
118
-
-
84864674632
-
Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting
-
Lando, H. M., Alattar, M., and Dua, A. P. (2012). Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting. Endocr. Pract. 18, 472-477.
-
(2012)
Endocr. Pract.
, vol.18
, pp. 472-477
-
-
Lando, H.M.1
Alattar, M.2
Dua, A.P.3
-
119
-
-
84861737062
-
Two novel GPER agonists induce gene expression changes and growth effects in cancer cells
-
Lappano, R., Rosano, C., Santolla, M. F., Pupo, M., De Francesco, E. M., De Marco, P., et al. (2012). Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Curr. Cancer Drug Targets 12, 531-542.
-
(2012)
Curr. Cancer Drug Targets
, vol.12
, pp. 531-542
-
-
Lappano, R.1
Rosano, C.2
Santolla, M.F.3
Pupo, M.4
De Francesco, E.M.5
De Marco, P.6
-
120
-
-
34047275592
-
Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens
-
Leblanc, K., Sexton, E., Parent, S., Belanger, G., Dery, M. C., Boucher, V., et al. (2007). Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens. Int. J. Oncol. 30, 477-487.
-
(2007)
Int. J. Oncol.
, vol.30
, pp. 477-487
-
-
Leblanc, K.1
Sexton, E.2
Parent, S.3
Belanger, G.4
Dery, M.C.5
Boucher, V.6
-
121
-
-
79959564813
-
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
-
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G., et al. (2011). Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 474, 521-525.
-
(2011)
Nature
, vol.474
, pp. 521-525
-
-
Lebon, G.1
Warne, T.2
Edwards, P.C.3
Bennett, K.4
Langmead, C.J.5
Leslie, A.G.6
-
122
-
-
77951622241
-
The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin
-
Lee, D. K., Ferguson, S. S., George, S. R., and O'Dowd, B. F. (2010). The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin. Biochem. Biophys. Res. Commun. 395, 185-189.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.395
, pp. 185-189
-
-
Lee, D.K.1
Ferguson, S.S.2
George, S.R.3
O'Dowd, B.F.4
-
123
-
-
84862776738
-
Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR
-
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., and Wuthrich, K. (2012). Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR. Science 335, 1106-1110.
-
(2012)
Science
, vol.335
, pp. 1106-1110
-
-
Liu, J.J.1
Horst, R.2
Katritch, V.3
Stevens, R.C.4
Wuthrich, K.5
-
125
-
-
71849107983
-
Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer
-
Logsdon, C. D., and Ji, B. (2009). Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin. Gastroenterol. Hepatol. 7, S40-S43.
-
(2009)
Clin. Gastroenterol. Hepatol.
, vol.7
-
-
Logsdon, C.D.1
Ji, B.2
-
126
-
-
77957958535
-
Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens
-
Lorand, T., Vigh, E., and Garai, J. (2010). Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens. Curr. Med. Chem. 17, 3542-3574.
-
(2010)
Curr. Med. Chem.
, vol.17
, pp. 3542-3574
-
-
Lorand, T.1
Vigh, E.2
Garai, J.3
-
127
-
-
77958017639
-
Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy
-
Lu, C., Everhart, L., Tilan, J., Kuo, L., Sun, C. C., Munivenkatappa, R. B., et al. (2010). Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene 29, 5630-5642.
-
(2010)
Oncogene
, vol.29
, pp. 5630-5642
-
-
Lu, C.1
Everhart, L.2
Tilan, J.3
Kuo, L.4
Sun, C.C.5
Munivenkatappa, R.B.6
-
128
-
-
77952415656
-
Beyond desensitization: physiological relevance of arrestin-dependent signaling
-
Luttrell, L. M., and Gesty-Palmer, D. (2010). Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol. Rev. 62, 305-330.
-
(2010)
Pharmacol. Rev.
, vol.62
, pp. 305-330
-
-
Luttrell, L.M.1
Gesty-Palmer, D.2
-
129
-
-
0346732301
-
Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways
-
MacDonald, P. E., Wang, X., Xia, F., El-kholy, W., Targonsky, E. D., Tsushima, R. G., et al. (2003). Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways. J. Biol. Chem. 278, 52446-52453.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 52446-52453
-
-
MacDonald, P.E.1
Wang, X.2
Xia, F.3
El-kholy, W.4
Targonsky, E.D.5
Tsushima, R.G.6
-
130
-
-
72549112513
-
Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer
-
Machens, A., Hoffmann, F., Sekulla, C., and Dralle, H. (2009). Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr. Relat. Cancer 16, 1291-1298.
-
(2009)
Endocr. Relat. Cancer
, vol.16
, pp. 1291-1298
-
-
Machens, A.1
Hoffmann, F.2
Sekulla, C.3
Dralle, H.4
-
131
-
-
59349108585
-
Treatment of type 2 diabetes with incretin-based therapies
-
Madsbad, S. (2009). Treatment of type 2 diabetes with incretin-based therapies. Lancet 373, 438-439.
-
(2009)
Lancet
, vol.373
, pp. 438-439
-
-
Madsbad, S.1
-
132
-
-
84857422717
-
GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation
-
Madsen, L. W., Knauf, J. A., Gotfredsen, C., Pilling, A., Sjogren, I., Andersen, S., et al. (2012). GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology 153, 1538-1547.
-
(2012)
Endocrinology
, vol.153
, pp. 1538-1547
-
-
Madsen, L.W.1
Knauf, J.A.2
Gotfredsen, C.3
Pilling, A.4
Sjogren, I.5
Andersen, S.6
-
133
-
-
17644406373
-
Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation
-
Mathieu, A., Clerc, P., Portolan, G., Bierkamp, C., Lulka, H., Pradayrol, L., et al. (2005). Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation. Int. J. Cancer 115, 46-54.
-
(2005)
Int. J. Cancer
, vol.115
, pp. 46-54
-
-
Mathieu, A.1
Clerc, P.2
Portolan, G.3
Bierkamp, C.4
Lulka, H.5
Pradayrol, L.6
-
134
-
-
15244346716
-
Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon
-
Matusiak, D., Glover, S., Nathaniel, R., Matkowskyj, K., Yang, J., and Benya, R. V. (2005). Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G718-G728.
-
(2005)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.288
-
-
Matusiak, D.1
Glover, S.2
Nathaniel, R.3
Matkowskyj, K.4
Yang, J.5
Benya, R.V.6
-
135
-
-
0037373183
-
International union of pharmacology
-
Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Goke, B., Thorens, B., et al. (2003). International union of pharmacology. XXXV. The glucagon receptor family. Pharmacol. Rev. 55, 167-194.
-
(2003)
XXXV. The glucagon receptor family. Pharmacol. Rev.
, vol.55
, pp. 167-194
-
-
Mayo, K.E.1
Miller, L.J.2
Bataille, D.3
Dalle, S.4
Goke, B.5
Thorens, B.6
-
136
-
-
0000661662
-
The molecular pharmacology of SERMs
-
McDonnell, D. P. (1999). The molecular pharmacology of SERMs. Trends Endocrinol. Metab. 10, 301-311.
-
(1999)
Trends Endocrinol. Metab.
, vol.10
, pp. 301-311
-
-
McDonnell, D.P.1
-
137
-
-
24944441782
-
Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates
-
Means, A. L., Meszoely, I. M., Suzuki, K., Miyamoto, Y., Rustgi, A. K., Coffey, R. J., et al. (2005). Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132, 3767-3776.
-
(2005)
Development
, vol.132
, pp. 3767-3776
-
-
Means, A.L.1
Meszoely, I.M.2
Suzuki, K.3
Miyamoto, Y.4
Rustgi, A.K.5
Coffey, R.J.6
-
138
-
-
84861589886
-
Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line
-
Medeiros, P. J., Al-Khazraji, B. K., Novielli, N. M., Postovit, L. M., Chambers, A. F., and Jackson, D. N. (2012). Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line. Int. J. Cancer 131, 276-286.
-
(2012)
Int. J. Cancer
, vol.131
, pp. 276-286
-
-
Medeiros, P.J.1
Al-Khazraji, B.K.2
Novielli, N.M.3
Postovit, L.M.4
Chambers, A.F.5
Jackson, D.N.6
-
139
-
-
72849129415
-
The comorbidity of diabetes mellitus and psychiatric disorders
-
Medved, V., Jovanovic, N., and Knapic, V. P. (2009). The comorbidity of diabetes mellitus and psychiatric disorders. Psychiatr. Danub. 21, 585-588.
-
(2009)
Psychiatr. Danub.
, vol.21
, pp. 585-588
-
-
Medved, V.1
Jovanovic, N.2
Knapic, V.P.3
-
140
-
-
68949131242
-
ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis
-
Meyer, M. R., and Barton, M. (2009). ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc. Res. 83, 605-610.
-
(2009)
Cardiovasc. Res.
, vol.83
, pp. 605-610
-
-
Meyer, M.R.1
Barton, M.2
-
141
-
-
67449152265
-
Non-genomic regulation of vascular cell function and growth by estrogen
-
Meyer, M. R., Haas, E., Prossnitz, E. R., and Barton, M. (2009). Non-genomic regulation of vascular cell function and growth by estrogen. Mol. Cell. Endocrinol. 308, 9-16.
-
(2009)
Mol. Cell. Endocrinol.
, vol.308
, pp. 9-16
-
-
Meyer, M.R.1
Haas, E.2
Prossnitz, E.R.3
Barton, M.4
-
142
-
-
0023107555
-
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
-
Mojsov, S., Weir, G. C., and Habener, J. F. (1987). Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79, 616-619.
-
(1987)
J. Clin. Invest.
, vol.79
, pp. 616-619
-
-
Mojsov, S.1
Weir, G.C.2
Habener, J.F.3
-
143
-
-
77955274496
-
Prokineticins in angiogenesis and cancer
-
Monnier, J., and Samson, M. (2010). Prokineticins in angiogenesis and cancer. Cancer Lett. 296, 144-149.
-
(2010)
Cancer Lett.
, vol.296
, pp. 144-149
-
-
Monnier, J.1
Samson, M.2
-
144
-
-
84861549027
-
Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells
-
Moody, T. W., Osefo, N., Nuche-Berenguer, B., Ridnour, L., Wink, D., and Jensen, R. T. (2012). Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. J. Pharmacol. Exp. Ther. 341, 873-881.
-
(2012)
J. Pharmacol. Exp. Ther.
, vol.341
, pp. 873-881
-
-
Moody, T.W.1
Osefo, N.2
Nuche-Berenguer, B.3
Ridnour, L.4
Wink, D.5
Jensen, R.T.6
-
145
-
-
0034352291
-
VPAC1 receptors and lung cancer
-
Moody, T. W., Walters, J., Casibang, M., Zia, F., and Gozes, Y. (2000). VPAC1 receptors and lung cancer. Ann. N. Y. Acad. Sci. 921, 26-32.
-
(2000)
Ann. N. Y. Acad. Sci.
, vol.921
, pp. 26-32
-
-
Moody, T.W.1
Walters, J.2
Casibang, M.3
Zia, F.4
Gozes, Y.5
-
146
-
-
80053348156
-
Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells
-
doi:10.1186/1471-2407-11-421
-
Muller, K. M., Tveteraas, I. H., Aasrum, M., Odegard, J., Dawood, M., Dajani, O., et al. (2011). Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells. BMC Cancer 11:421. doi:10.1186/1471-2407-11-421
-
(2011)
BMC Cancer
, vol.11
, pp. 421
-
-
Muller, K.M.1
Tveteraas, I.H.2
Aasrum, M.3
Odegard, J.4
Dawood, M.5
Dajani, O.6
-
147
-
-
72449157026
-
Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
-
Nachnani J S., Bulchandani, D. G., Nookala, A., Herndon, B., Molteni, A., Pandya, P., et al. (2010). Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia 53, 153-159.
-
(2010)
Diabetologia
, vol.53
, pp. 153-159
-
-
Nachnani, J.S.1
Bulchandani, D.G.2
Nookala, A.3
Herndon, B.4
Molteni, A.5
Pandya, P.6
-
148
-
-
84864621482
-
Reduced intestinal tumorigenesis in APCmin mice lacking melanin-concentrating hormone
-
doi:10.1371/journal.pone.0041914
-
Nagel, J. M., Geiger, B. M., Karagiannis, A. K., Gras-Miralles, B., Horst, D., Najarian, R. M., et al. (2012). Reduced intestinal tumorigenesis in APCmin mice lacking melanin-concentrating hormone. PLoS ONE 7:e41914. doi:10.1371/journal.pone.0041914
-
(2012)
PLoS ONE
, vol.7
-
-
Nagel, J.M.1
Geiger, B.M.2
Karagiannis, A.K.3
Gras-Miralles, B.4
Horst, D.5
Najarian, R.M.6
-
149
-
-
37249034101
-
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
-
Nasrallah, H. A. (2008). Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol. Psychiatry 13, 27-35.
-
(2008)
Mol. Psychiatry
, vol.13
, pp. 27-35
-
-
Nasrallah, H.A.1
-
150
-
-
0027391607
-
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
-
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., and Creutzfeldt, W. (1993). Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91, 301-307.
-
(1993)
J. Clin. Invest.
, vol.91
, pp. 301-307
-
-
Nauck, M.A.1
Heimesaat, M.M.2
Orskov, C.3
Holst, J.J.4
Ebert, R.5
Creutzfeldt, W.6
-
151
-
-
75549091061
-
Incretin-based therapies: viewpoints on the way to consensus
-
Nauck, M. A., Vilsboll, T., Gallwitz, B., Garber, A., and Madsbad, S. (2009). Incretin-based therapies: viewpoints on the way to consensus. Diabetes Care 32(Suppl. 2), S223-S231.
-
(2009)
Diabetes Care
, vol.32
, Issue.SUPPL. 2
-
-
Nauck, M.A.1
Vilsboll, T.2
Gallwitz, B.3
Garber, A.4
Madsbad, S.5
-
152
-
-
84860577431
-
The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species
-
Nyborg, N. C., Molck, A. M., Madsen, L. W., and Knudsen, L. B. (2012). The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species. Diabetes 61, 1243-1249.
-
(2012)
Diabetes
, vol.61
, pp. 1243-1249
-
-
Nyborg, N.C.1
Molck, A.M.2
Madsen, L.W.3
Knudsen, L.B.4
-
153
-
-
78649735494
-
Molecularly targeted endocrine therapies for breast cancer
-
Orlando, L., Schiavone, P., Fedele, P., Calvani, N., Nacci, A., Rizzo, P., et al. (2010). Molecularly targeted endocrine therapies for breast cancer. Cancer Treat. Rev. 36(Suppl. 3), S67-S71.
-
(2010)
Cancer Treat. Rev.
, vol.36
, Issue.SUPPL. 3
-
-
Orlando, L.1
Schiavone, P.2
Fedele, P.3
Calvani, N.4
Nacci, A.5
Rizzo, P.6
-
154
-
-
53249107839
-
G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol
-
Otto, C., Rohde-Schulz, B., Schwarz, G., Fuchs, I., Klewer, M., Brittain, D., et al. (2008). G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 149, 4846-4856.
-
(2008)
Endocrinology
, vol.149
, pp. 4846-4856
-
-
Otto, C.1
Rohde-Schulz, B.2
Schwarz, G.3
Fuchs, I.4
Klewer, M.5
Brittain, D.6
-
155
-
-
84255168020
-
Diabetes mellitus and the risk of cancer
-
Pandey, A., Forte, V., Abdallah, M., Alickaj, A., Mahmud, S., Asad, S., et al. (2011). Diabetes mellitus and the risk of cancer. Minerva Endocrinol. 36, 187-209.
-
(2011)
Minerva Endocrinol.
, vol.36
, pp. 187-209
-
-
Pandey, A.1
Forte, V.2
Abdallah, M.3
Alickaj, A.4
Mahmud, S.5
Asad, S.6
-
156
-
-
62049084027
-
Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
-
Pandey, D. P., Lappano, R., Albanito, L., Madeo, A., Maggiolini, M., and Picard, D. (2009). Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 28, 523-532.
-
(2009)
EMBO J.
, vol.28
, pp. 523-532
-
-
Pandey, D.P.1
Lappano, R.2
Albanito, L.3
Madeo, A.4
Maggiolini, M.5
Picard, D.6
-
157
-
-
80053304908
-
Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo
-
Park, H. J., Kim, S. R., Kim, M. K., Choi, K. S., Jang, H. O., Yun, I., et al. (2011). Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo. Cancer Lett. 312, 117-127.
-
(2011)
Cancer Lett.
, vol.312
, pp. 117-127
-
-
Park, H.J.1
Kim, S.R.2
Kim, M.K.3
Choi, K.S.4
Jang, H.O.5
Yun, I.6
-
158
-
-
33644850386
-
Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function
-
Park, S., Dong, X., Fisher, T. L., Dunn, S., Omer, A. K., Weir, G., et al. (2006). Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J. Biol. Chem. 281, 1159-1168.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 1159-1168
-
-
Park, S.1
Dong, X.2
Fisher, T.L.3
Dunn, S.4
Omer, A.K.5
Weir, G.6
-
159
-
-
33747841976
-
Nature of functional estrogen receptors at the plasma membrane
-
Pedram, A., Razandi, M., and Levin, E. R. (2006). Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20, 1996-2009.
-
(2006)
Mol. Endocrinol.
, vol.20
, pp. 1996-2009
-
-
Pedram, A.1
Razandi, M.2
Levin, E.R.3
-
160
-
-
84860112131
-
What we have learned about pancreatic cancer from mouse models
-
Perez-Mancera, P. A., Guerra, C., Barbacid, M., and Tuveson, D. A. (2012). What we have learned about pancreatic cancer from mouse models. Gastroenterology 142, 1079-1092.
-
(2012)
Gastroenterology
, vol.142
, pp. 1079-1092
-
-
Perez-Mancera, P.A.1
Guerra, C.2
Barbacid, M.3
Tuveson, D.A.4
-
162
-
-
4444373076
-
Prevention of cancers of the breast, endometrium and ovary
-
Pike, M. C., Pearce, C. L., and Wu, A. H. (2004). Prevention of cancers of the breast, endometrium and ovary. Oncogene 23, 6379-6391.
-
(2004)
Oncogene
, vol.23
, pp. 6379-6391
-
-
Pike, M.C.1
Pearce, C.L.2
Wu, A.H.3
-
163
-
-
34548612361
-
Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat
-
Piteau, S., Olver, A., Kim, S. J., Winter, K., Pospisilik, J. A., Lynn, F., et al. (2007). Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat. Biochem. Biophys. Res. Commun. 362, 1007-1012.
-
(2007)
Biochem. Biophys. Res. Commun.
, vol.362
, pp. 1007-1012
-
-
Piteau, S.1
Olver, A.2
Kim, S.J.3
Winter, K.4
Pospisilik, J.A.5
Lynn, F.6
-
164
-
-
33847773775
-
Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial
-
Powles, T. J., Ashley, S., Tidy, A., Smith, I. E., and Dowsett, M. (2007). Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J. Natl. Cancer Inst. 99, 283-290.
-
(2007)
J. Natl. Cancer Inst.
, vol.99
, pp. 283-290
-
-
Powles, T.J.1
Ashley, S.2
Tidy, A.3
Smith, I.E.4
Dowsett, M.5
-
165
-
-
60549097258
-
Targeting incretins in Type 2 diabetes: role of GLP-1 receptor agonists and DPP-4 inhibitors
-
Pratley, R. E., and Gilbert, M. (2008). Targeting incretins in Type 2 diabetes: role of GLP-1 receptor agonists and DPP-4 inhibitors. Rev. Diabet. Stud. 5, 73-94.
-
(2008)
Rev. Diabet. Stud.
, vol.5
, pp. 73-94
-
-
Pratley, R.E.1
Gilbert, M.2
-
166
-
-
43549095238
-
Estrogen signaling through the transmembrane G protein-coupled receptor GPR30
-
Prossnitz, E. R., Arterburn, J. B., Smith, H. O., Oprea, T. I., Sklar, L. A., and Hathaway, H. J. (2008a). Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 70, 165-190.
-
(2008)
Annu. Rev. Physiol.
, vol.70
, pp. 165-190
-
-
Prossnitz, E.R.1
Arterburn, J.B.2
Smith, H.O.3
Oprea, T.I.4
Sklar, L.A.5
Hathaway, H.J.6
-
167
-
-
43849100632
-
The ins and outs of GPR30: a transmembrane estrogen receptor
-
Prossnitz, E. R., Oprea, T. I., Sklar, L. A., and Arterburn, J. B. (2008b). The ins and outs of GPR30: a transmembrane estrogen receptor. J. Steroid Biochem. Mol. Biol. 109, 350-353.
-
(2008)
J. Steroid Biochem. Mol. Biol.
, vol.109
, pp. 350-353
-
-
Prossnitz, E.R.1
Oprea, T.I.2
Sklar, L.A.3
Arterburn, J.B.4
-
168
-
-
76249122645
-
GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells
-
Quoyer, J., Longuet, C., Broca, C., Linck, N., Costes, S., Varin, E., et al. (2010). GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. J. Biol. Chem. 285, 1989-2002.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 1989-2002
-
-
Quoyer, J.1
Longuet, C.2
Broca, C.3
Linck, N.4
Costes, S.5
Varin, E.6
-
169
-
-
68149160827
-
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis
-
Rafei, M., Berchiche, Y. A., Birman, E., Boivin, M. N., Young, Y. K., Wu, J. H., et al. (2009). An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. J. Immunol. 183, 1759-1766.
-
(2009)
J. Immunol.
, vol.183
, pp. 1759-1766
-
-
Rafei, M.1
Berchiche, Y.A.2
Birman, E.3
Boivin, M.N.4
Young, Y.K.5
Wu, J.H.6
-
170
-
-
84860201432
-
Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy
-
Rahmeh, R., Damian, M., Cottet, M., Orcel, H., Mendre, C., Durroux, T., et al. (2012). Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 109, 6733-6738.
-
(2012)
Proc. Natl. Acad. Sci. U.S.A.
, vol.109
, pp. 6733-6738
-
-
Rahmeh, R.1
Damian, M.2
Cottet, M.3
Orcel, H.4
Mendre, C.5
Durroux, T.6
-
171
-
-
77951844975
-
Teaching old receptors new tricks: biasing seven-transmembrane receptors
-
Rajagopal, S., Rajagopal, K., and Lefkowitz, R. J. (2010a). Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9, 373-386.
-
(2010)
Nat. Rev. Drug Discov.
, vol.9
, pp. 373-386
-
-
Rajagopal, S.1
Rajagopal, K.2
Lefkowitz, R.J.3
-
172
-
-
76249134336
-
Beta-arrestin- but not G protein-mediated signaling by the decoy receptor CXCR7
-
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., et al. (2010b). Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc. Natl. Acad. Sci. U.S.A. 107, 628-632.
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 628-632
-
-
Rajagopal, S.1
Kim, J.2
Ahn, S.3
Craig, S.4
Lam, C.M.5
Gerard, N.P.6
-
173
-
-
58249089866
-
The natural history of hereditary pancreatitis: a national series
-
Rebours, V., Boutron-Ruault, M. C., Schnee, M., Ferec, C., Le Marechal, C., Hentic, O., et al. (2009). The natural history of hereditary pancreatitis: a national series. Gut 58, 97-103.
-
(2009)
Gut
, vol.58
, pp. 97-103
-
-
Rebours, V.1
Boutron-Ruault, M.C.2
Schnee, M.3
Ferec, C.4
Le Marechal, C.5
Hentic, O.6
-
174
-
-
14844343093
-
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
-
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., and Prossnitz, E. R. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630.
-
(2005)
Science
, vol.307
, pp. 1625-1630
-
-
Revankar, C.M.1
Cimino, D.F.2
Sklar, L.A.3
Arterburn, J.B.4
Prossnitz, E.R.5
-
175
-
-
18144422077
-
The oxytocin receptor antagonist atosiban inhibits cell growth via a biased agonist mechanism
-
Reversi, A., Rimoldi, V., Marrocco, T., Cassoni, P., Bussolati, G., Parenti, M., et al. (2005). The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J. Biol. Chem. 280, 16311-16318.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 16311-16318
-
-
Reversi, A.1
Rimoldi, V.2
Marrocco, T.3
Cassoni, P.4
Bussolati, G.5
Parenti, M.6
-
176
-
-
11244296162
-
Mechanisms of tamoxifen resistance
-
Ring, A., and Dowsett, M. (2004). Mechanisms of tamoxifen resistance. Endocr. Relat. Cancer 11, 643-658.
-
(2004)
Endocr. Relat. Cancer
, vol.11
, pp. 643-658
-
-
Ring, A.1
Dowsett, M.2
-
177
-
-
0034677745
-
Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers
-
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., and Patel, Y. C. (2000). Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 275, 7862-7869.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 7862-7869
-
-
Rocheville, M.1
Lange, D.C.2
Kumar, U.3
Sasi, R.4
Patel, R.C.5
Patel, Y.C.6
-
178
-
-
84859997943
-
Angiotensin II facilitates breast cancer cell migration and metastasis
-
doi:10.1371/journal.pone.0035667
-
Rodrigues-Ferreira, S., Abdelkarim, M., Dillenburg-Pilla, P., Luissint, A. C., di-Tommaso, A., Deshayes, F., et al. (2012). Angiotensin II facilitates breast cancer cell migration and metastasis. PLoS ONE 7:e35667. doi:10.1371/journal.pone.0035667
-
(2012)
PLoS ONE
, vol.7
-
-
Rodrigues-Ferreira, S.1
Abdelkarim, M.2
Dillenburg-Pilla, P.3
Luissint, A.C.4
di-Tommaso, A.5
Deshayes, F.6
-
179
-
-
0033616765
-
The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2
-
Rodriguez-Frade, J. M., Vila-Coro, A. J., de Ana, A. M., Albar, J. P., Martinez, A. C., and Mellado, M. (1999). The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl. Acad. Sci. U.S.A. 96, 3628-3633.
-
(1999)
Proc. Natl. Acad. Sci. U.S.A.
, vol.96
, pp. 3628-3633
-
-
Rodriguez-Frade, J.M.1
Vila-Coro, A.J.2
de Ana, A.M.3
Albar, J.P.4
Martinez, A.C.5
Mellado, M.6
-
180
-
-
32644453155
-
Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells
-
Ruscica, M., Dozio, E., Boghossian, S., Bovo, G., Martos Riano, V., Motta, M., et al. (2006). Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells. Endocrinology 147, 1466-1473.
-
(2006)
Endocrinology
, vol.147
, pp. 1466-1473
-
-
Ruscica, M.1
Dozio, E.2
Boghossian, S.3
Bovo, G.4
Martos Riano, V.5
Motta, M.6
-
181
-
-
79951987933
-
G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments
-
Sanden, C., Broselid, S., Cornmark, L., Andersson, K., Daszkiewicz-Nilsson, J., Martensson, U. E., et al. (2011). G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol. Pharmacol. 79, 400-410.
-
(2011)
Mol. Pharmacol.
, vol.79
, pp. 400-410
-
-
Sanden, C.1
Broselid, S.2
Cornmark, L.3
Andersson, K.4
Daszkiewicz-Nilsson, J.5
Martensson, U.E.6
-
182
-
-
0029759541
-
Annual hazard rates of recurrence for breast cancer after primary therapy
-
Saphner, T., Tormey, D. C., and Gray, R. (1996). Annual hazard rates of recurrence for breast cancer after primary therapy. J. Clin. Oncol. 14, 2738-2746.
-
(1996)
J. Clin. Oncol.
, vol.14
, pp. 2738-2746
-
-
Saphner, T.1
Tormey, D.C.2
Gray, R.3
-
183
-
-
64049106282
-
Metabolic complications of androgen deprivation therapy for prostate cancer
-
discussion 2007-2008
-
Saylor, P. J., and Smith, M. R. (2009). Metabolic complications of androgen deprivation therapy for prostate cancer. J. Urol. 181, 1998-2006. discussion 2007-2008.
-
(2009)
J. Urol.
, vol.181
, pp. 1998-2006
-
-
Saylor, P.J.1
Smith, M.R.2
-
184
-
-
0030641037
-
Alterations in steroid hormone receptors in the tamoxifen-treated endometrium
-
Schwartz, L. B., Krey, L., Demopoulos, R., Goldstein, S. R., Nachtigall, L. E., and Mittal, K. (1997). Alterations in steroid hormone receptors in the tamoxifen-treated endometrium. Am. J. Obstet. Gynecol. 176, 129-137.
-
(1997)
Am. J. Obstet. Gynecol.
, vol.176
, pp. 129-137
-
-
Schwartz, L.B.1
Krey, L.2
Demopoulos, R.3
Goldstein, S.R.4
Nachtigall, L.E.5
Mittal, K.6
-
185
-
-
25444520038
-
PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis
-
Seino, S., and Shibasaki, T. (2005). PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol. Rev. 85, 1303-1342.
-
(2005)
Physiol. Rev.
, vol.85
, pp. 1303-1342
-
-
Seino, S.1
Shibasaki, T.2
-
186
-
-
78649348967
-
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress
-
Sengupta, S., Peterson, T. R., and Sabatini, D. M. (2010). Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40, 310-322.
-
(2010)
Mol. Cell
, vol.40
, pp. 310-322
-
-
Sengupta, S.1
Peterson, T.R.2
Sabatini, D.M.3
-
187
-
-
42249096282
-
Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate
-
Sensken, S. C., Staubert, C., Keul, P., Levkau, B., Schoneberg, T., and Graler, M. H. (2008). Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate. Cell. Signal. 20, 1125-1133.
-
(2008)
Cell. Signal.
, vol.20
, pp. 1125-1133
-
-
Sensken, S.C.1
Staubert, C.2
Keul, P.3
Levkau, B.4
Schoneberg, T.5
Graler, M.H.6
-
188
-
-
77951152245
-
Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line
-
Sheriff, S., Ali, M., Yahya, A., Haider, K. H., Balasubramaniam, A., and Amlal, H. (2010). Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Mol. Cancer Res. 8, 604-614.
-
(2010)
Mol. Cancer Res.
, vol.8
, pp. 604-614
-
-
Sheriff, S.1
Ali, M.2
Yahya, A.3
Haider, K.H.4
Balasubramaniam, A.5
Amlal, H.6
-
189
-
-
71049145347
-
Estrogen receptor signaling in lung cancer
-
Siegfried, J. M., Hershberger, P. A., and Stabile, L. P. (2009). Estrogen receptor signaling in lung cancer. Semin. Oncol. 36, 524-531.
-
(2009)
Semin. Oncol.
, vol.36
, pp. 524-531
-
-
Siegfried, J.M.1
Hershberger, P.A.2
Stabile, L.P.3
-
190
-
-
33947697810
-
GPR30: a novel indicator of poor survival for endometrial carcinoma
-
discussion 386.e9-386.e11
-
Smith, H. O., Leslie, K. K., Singh, M., Qualls, C. R., Revankar, C. M., Joste, N. E., et al. (2007). GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 196, 386.e1-386.e9. discussion 386.e9-386.e11.
-
(2007)
Am. J. Obstet. Gynecol.
, vol.196
-
-
Smith, H.O.1
Leslie, K.K.2
Singh, M.3
Qualls, C.R.4
Revankar, C.M.5
Joste, N.E.6
-
191
-
-
77954553687
-
Of mice and men: divergent risks of teriparatide-induced osteosarcoma
-
Subbiah, V., Madsen, V. S., Raymond, A. K., Benjamin, R. S., and Ludwig, J. A. (2010). Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos. Int. 21, 1041-1045.
-
(2010)
Osteoporos. Int.
, vol.21
, pp. 1041-1045
-
-
Subbiah, V.1
Madsen, V.S.2
Raymond, A.K.3
Benjamin, R.S.4
Ludwig, J.A.5
-
192
-
-
84857781490
-
Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells
-
Suzuki, K., Nakabayashi, K., Yamada, A. Y., Lodhi, R. S., Hazama, R., Ebina, Y., et al. (2012). Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells. Fertil. Steril. 97, 734-741.
-
(2012)
Fertil. Steril.
, vol.97
, pp. 734-741
-
-
Suzuki, K.1
Nakabayashi, K.2
Yamada, A.Y.3
Lodhi, R.S.4
Hazama, R.5
Ebina, Y.6
-
193
-
-
84858287886
-
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders
-
Tack, J., Camilleri, M., Chang, L., Chey, W. D., Galligan, J. J., Lacy, B. E., et al. (2012). Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment. Pharmacol. Ther. 35, 745-767.
-
(2012)
Aliment. Pharmacol. Ther.
, vol.35
, pp. 745-767
-
-
Tack, J.1
Camilleri, M.2
Chang, L.3
Chey, W.D.4
Galligan, J.J.5
Lacy, B.E.6
-
194
-
-
78649658112
-
Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
-
Tatarkiewicz, K., Smith, P. A., Sablan, E. J., Polizzi, C. J., Aumann, D. E., Villescaz, C., et al. (2010). Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents. Am. J. Physiol. Endocrinol. Metab. 299, E1076-E1086.
-
(2010)
Am. J. Physiol. Endocrinol. Metab.
, vol.299
-
-
Tatarkiewicz, K.1
Smith, P.A.2
Sablan, E.J.3
Polizzi, C.J.4
Aumann, D.E.5
Villescaz, C.6
-
195
-
-
33750992478
-
Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption
-
Thomas, P., and Dong, J. (2006). Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 102, 175-179.
-
(2006)
J. Steroid Biochem. Mol. Biol.
, vol.102
, pp. 175-179
-
-
Thomas, P.1
Dong, J.2
-
196
-
-
12344307170
-
Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells
-
Thomas, P., Pang, Y., Filardo, E. J., and Dong, J. (2005). Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146, 624-632.
-
(2005)
Endocrinology
, vol.146
, pp. 624-632
-
-
Thomas, P.1
Pang, Y.2
Filardo, E.J.3
Dong, J.4
-
197
-
-
0026775150
-
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1
-
Thorens, B. (1992). Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U.S.A. 89, 8641-8645.
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 8641-8645
-
-
Thorens, B.1
-
198
-
-
84865348887
-
The proliferative effects of ghrelin on human gastric cancer AGS cells
-
Tian, P. Y., and Fan, X. M. (2012). The proliferative effects of ghrelin on human gastric cancer AGS cells. J. Dig. Dis. 13, 453-458.
-
(2012)
J. Dig. Dis.
, vol.13
, pp. 453-458
-
-
Tian, P.Y.1
Fan, X.M.2
-
199
-
-
49749113817
-
Expression of the GLP-1 receptor in mouse, rat, and human pancreas
-
Tornehave, D., Kristensen, P., Romer, J., Knudsen, L. B., and Heller, R. S. (2008). Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J. Histochem. Cytochem. 56, 841-851.
-
(2008)
J. Histochem. Cytochem.
, vol.56
, pp. 841-851
-
-
Tornehave, D.1
Kristensen, P.2
Romer, J.3
Knudsen, L.B.4
Heller, R.S.5
-
200
-
-
57349130501
-
Exenatide and acute pancreatitis
-
Tripathy, N. R., Basha, S., Jain, R., Shetty, S., and Ramachandran, A. (2008). Exenatide and acute pancreatitis. J. Assoc. Physicians India 56, 987-988.
-
(2008)
J. Assoc. Physicians India
, vol.56
, pp. 987-988
-
-
Tripathy, N.R.1
Basha, S.2
Jain, R.3
Shetty, S.4
Ramachandran, A.5
-
201
-
-
23844487799
-
The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells
-
Trumper, J., Ross, D., Jahr, H., Brendel, M. D., Goke, R., and Horsch, D. (2005). The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells. Diabetologia 48, 1534-1540.
-
(2005)
Diabetologia
, vol.48
, pp. 1534-1540
-
-
Trumper, J.1
Ross, D.2
Jahr, H.3
Brendel, M.D.4
Goke, R.5
Horsch, D.6
-
202
-
-
84884172044
-
Victoza (Liraglutide [rDNA Origin]) Injection: REMS-Risk of Thyroid C-Cell Tumors, Acute Pancreatitis
-
U.S. Food and Drug Administration., Available at [accessed April]
-
U.S. Food and Drug Administration. (2011). Victoza (Liraglutide [rDNA Origin]) Injection: REMS-Risk of Thyroid C-Cell Tumors, Acute Pancreatitis. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm [accessed April 30, 2012].
-
(2011)
, vol.30
, pp. 2012
-
-
-
203
-
-
78149496656
-
The role of conformational ensembles of seven transmembrane receptors in functional selectivity
-
Vaidehi, N., and Kenakin, T. (2010). The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr. Opin. Pharmacol. 10, 775-781.
-
(2010)
Curr. Opin. Pharmacol.
, vol.10
, pp. 775-781
-
-
Vaidehi, N.1
Kenakin, T.2
-
204
-
-
80755138420
-
RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells
-
Valdehita, A., Carmena, M. J., Bajo, A. M., and Prieto, J. C. (2012). RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells. Mol. Cell. Endocrinol. 348, 241-246.
-
(2012)
Mol. Cell. Endocrinol.
, vol.348
, pp. 241-246
-
-
Valdehita, A.1
Carmena, M.J.2
Bajo, A.M.3
Prieto, J.C.4
-
205
-
-
0028053224
-
Risk of endometrial cancer after tamoxifen treatment of breast cancer
-
van Leeuwen, F. E., Benraadt, J., Coebergh, J. W., Kiemeney, L. A., Gimbrere, C. H., Otter, R., et al. (1994). Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343, 448-452.
-
(1994)
Lancet
, vol.343
, pp. 448-452
-
-
van Leeuwen, F.E.1
Benraadt, J.2
Coebergh, J.W.3
Kiemeney, L.A.4
Gimbrere, C.H.5
Otter, R.6
-
206
-
-
84884195180
-
-
Victoza (Liraglutide) Injection [accessed April]
-
Victoza (Liraglutide) Injection. (2012). Novo Nordisk. Available at: http://www.novo-pi.com/victoza.pdf [accessed April 30, 2012].
-
(2012)
Novo Nordisk. Available at
, vol.30
, pp. 2012
-
-
-
207
-
-
0034724420
-
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
-
Vila-Coro, A. J., Mellado, M., Martin de Ana, A., Lucas, P., del Real, G., Martinez, A. C., et al. (2000). HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. U.S.A. 97, 3388-3393.
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 3388-3393
-
-
Vila-Coro, A.J.1
Mellado, M.2
Martin de Ana, A.3
Lucas, P.4
del Real, G.5
Martinez, A.C.6
-
208
-
-
73349106529
-
The effects of glucagon-like peptide-1 on the beta cell
-
Vilsboll, T. (2009). The effects of glucagon-like peptide-1 on the beta cell. Diabetes Obes. Metab. 11(Suppl. 3), 11-18.
-
(2009)
Diabetes Obes. Metab.
, vol.11
, Issue.SUPPL. 3
, pp. 11-18
-
-
Vilsboll, T.1
-
209
-
-
39749143348
-
Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
-
Vilsboll, T., Brock, B., Perrild, H., Levin, K., Lervang, H. H., Kolendorf, K., et al. (2008). Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. Diabet. Med. 25, 152-156.
-
(2008)
Diabet. Med.
, vol.25
, pp. 152-156
-
-
Vilsboll, T.1
Brock, B.2
Perrild, H.3
Levin, K.4
Lervang, H.H.5
Kolendorf, K.6
-
210
-
-
0036373430
-
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients
-
Vilsboll, T., Krarup, T., Madsbad, S., and Holst, J. J. (2002). Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia 45, 1111-1119.
-
(2002)
Diabetologia
, vol.45
, pp. 1111-1119
-
-
Vilsboll, T.1
Krarup, T.2
Madsbad, S.3
Holst, J.J.4
-
211
-
-
34249869806
-
Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes
-
Vilsboll, T., Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Courreges, J. P., et al. (2007). Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes. Diabetes Care 30, 1608-1610.
-
(2007)
Diabetes Care
, vol.30
, pp. 1608-1610
-
-
Vilsboll, T.1
Zdravkovic, M.2
Le-Thi, T.3
Krarup, T.4
Schmitz, O.5
Courreges, J.P.6
-
212
-
-
33344461590
-
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells
-
Vivacqua, A., Bonofiglio, D., Recchia, A. G., Musti, A. M., Picard, D., Ando, S., et al. (2006a). The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol. Endocrinol. 20, 631-646.
-
(2006)
Mol. Endocrinol.
, vol.20
, pp. 631-646
-
-
Vivacqua, A.1
Bonofiglio, D.2
Recchia, A.G.3
Musti, A.M.4
Picard, D.5
Ando, S.6
-
213
-
-
33748923143
-
17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30
-
Vivacqua, A., Bonofiglio, D., Albanito, L., Madeo, A., Rago, V., Carpino, A., et al. (2006b). 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30. Mol. Pharmacol. 70, 1414-1423.
-
(2006)
Mol. Pharmacol.
, vol.70
, pp. 1414-1423
-
-
Vivacqua, A.1
Bonofiglio, D.2
Albanito, L.3
Madeo, A.4
Rago, V.5
Carpino, A.6
-
214
-
-
84872024032
-
Emerging opportunities for allosteric modulation of G-protein coupled receptors
-
Wang, C. I., and Lewis, R. J. (2013). Emerging opportunities for allosteric modulation of G-protein coupled receptors. Biochem. Pharmacol. 85, 153-162.
-
(2013)
Biochem. Pharmacol.
, vol.85
, pp. 153-162
-
-
Wang, C.I.1
Lewis, R.J.2
-
215
-
-
77955334004
-
G protein-coupled receptor 30 in tumor development
-
Wang, D., Hu, L., Zhang, G., Zhang, L., and Chen, C. (2010). G protein-coupled receptor 30 in tumor development. Endocrine 38, 29-37.
-
(2010)
Endocrine
, vol.38
, pp. 29-37
-
-
Wang, D.1
Hu, L.2
Zhang, G.3
Zhang, L.4
Chen, C.5
-
216
-
-
78651405537
-
The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor
-
Warne, T., Moukhametzianov, R., Baker, J. G., Nehme, R., Edwards, P. C., Leslie, A. G., et al. (2011). The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature 469, 241-244.
-
(2011)
Nature
, vol.469
, pp. 241-244
-
-
Warne, T.1
Moukhametzianov, R.2
Baker, J.G.3
Nehme, R.4
Edwards, P.C.5
Leslie, A.G.6
-
217
-
-
83655191987
-
Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy
-
Waser, B., Beetschen, K., Pellegata, N. S., and Reubi, J. C. (2011). Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy. Neuroendocrinology 94, 291-301.
-
(2011)
Neuroendocrinology
, vol.94
, pp. 291-301
-
-
Waser, B.1
Beetschen, K.2
Pellegata, N.S.3
Reubi, J.C.4
-
218
-
-
84856776511
-
Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors
-
Waser, B., Rehmann, R., Sanchez, C., Fourmy, D., and Reubi, J. C. (2012). Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors. J. Clin. Endocrinol. Metab. 97, 482-488.
-
(2012)
J. Clin. Endocrinol. Metab.
, vol.97
, pp. 482-488
-
-
Waser, B.1
Rehmann, R.2
Sanchez, C.3
Fourmy, D.4
Reubi, J.C.5
-
219
-
-
77954473787
-
Selective modulation of follicle-stimulating hormone signaling pathways with enhancing equine chorionic gonadotropin/antibody immune complexes
-
Wehbi, V., Decourtye, J., Piketty, V., Durand, G., Reiter, E., and Maurel, M. C. (2010). Selective modulation of follicle-stimulating hormone signaling pathways with enhancing equine chorionic gonadotropin/antibody immune complexes. Endocrinology 151, 2788-2799.
-
(2010)
Endocrinology
, vol.151
, pp. 2788-2799
-
-
Wehbi, V.1
Decourtye, J.2
Piketty, V.3
Durand, G.4
Reiter, E.5
Maurel, M.C.6
-
220
-
-
0031000789
-
Specific, nongenomic actions of steroid hormones
-
Wehling, M. (1997). Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59, 365-393.
-
(1997)
Annu. Rev. Physiol.
, vol.59
, pp. 365-393
-
-
Wehling, M.1
-
221
-
-
0141703263
-
Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
-
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., et al. (2003). Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 100, 10782-10787.
-
(2003)
Proc. Natl. Acad. Sci. U.S.A.
, vol.100
, pp. 10782-10787
-
-
Wei, H.1
Ahn, S.2
Shenoy, S.K.3
Karnik, S.S.4
Hunyady, L.5
Luttrell, L.M.6
-
222
-
-
84862912924
-
Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation
-
Wei, Y., Zhang, Z., Liao, H., Wu, L., Wu, X., Zhou, D., et al. (2012). Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Oncol. Rep. 27, 504-510.
-
(2012)
Oncol. Rep.
, vol.27
, pp. 504-510
-
-
Wei, Y.1
Zhang, Z.2
Liao, H.3
Wu, L.4
Wu, X.5
Zhou, D.6
-
223
-
-
79952488185
-
Therapeutic potential of beta-arrestin- and G protein-biased agonists
-
Whalen, E. J., Rajagopal, S., and Lefkowitz, R. J. (2011). Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends. Mol. Med. 17, 126-139.
-
(2011)
Trends. Mol. Med.
, vol.17
, pp. 126-139
-
-
Whalen, E.J.1
Rajagopal, S.2
Lefkowitz, R.J.3
-
224
-
-
0036605575
-
Association of tamoxifen and uterine sarcoma
-
Wickerham, D. L., Fisher, B., Wolmark, N., Bryant, J., Costantino, J., Bernstein, L., et al. (2002). Association of tamoxifen and uterine sarcoma. J. Clin. Oncol. 20, 2758-2760.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 2758-2760
-
-
Wickerham, D.L.1
Fisher, B.2
Wolmark, N.3
Bryant, J.4
Costantino, J.5
Bernstein, L.6
-
225
-
-
84869842165
-
Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin
-
Willard, F. S., Wootten, D., Showalter, A. D., Savage, E. E., Ficorilli, J., Farb, T. B., et al. (2012). Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin. Mol. Pharmacol. 82, 1066-1073.
-
(2012)
Mol. Pharmacol.
, vol.82
, pp. 1066-1073
-
-
Willard, F.S.1
Wootten, D.2
Showalter, A.D.3
Savage, E.E.4
Ficorilli, J.5
Farb, T.B.6
-
226
-
-
36749094552
-
A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling
-
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., et al. (2007). A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc. Natl. Acad. Sci. U.S.A. 104, 16657-16662.
-
(2007)
Proc. Natl. Acad. Sci. U.S.A.
, vol.104
, pp. 16657-16662
-
-
Wisler, J.W.1
DeWire, S.M.2
Whalen, E.J.3
Violin, J.D.4
Drake, M.T.5
Ahn, S.6
-
227
-
-
84875426039
-
Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands
-
Wootten, D., Savage, E. E., Willard, F. S., Bueno, A. B., Sloop, K. W., Christopoulos, A., et al. (2013). Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands. Mol. Pharmacol. 83, 822-834.
-
(2013)
Mol. Pharmacol.
, vol.83
, pp. 822-834
-
-
Wootten, D.1
Savage, E.E.2
Willard, F.S.3
Bueno, A.B.4
Sloop, K.W.5
Christopoulos, A.6
-
228
-
-
78149290612
-
Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo
-
Wu, Y. Q., Song, Z., Zhou, C. H., Xing, S. H., Pei, D. S., and Zheng, J. N. (2010). Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo. Oncol. Rep. 24, 1179-1184.
-
(2010)
Oncol. Rep.
, vol.24
, pp. 1179-1184
-
-
Wu, Y.Q.1
Song, Z.2
Zhou, C.H.3
Xing, S.H.4
Pei, D.S.5
Zheng, J.N.6
-
229
-
-
79954782236
-
Structure of an agonist-bound human A2A adenosine receptor
-
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z. G., et al. (2011). Structure of an agonist-bound human A2A adenosine receptor. Science 332, 322-327.
-
(2011)
Science
, vol.332
, pp. 322-327
-
-
Xu, F.1
Wu, H.2
Katritch, V.3
Han, G.W.4
Jacobson, K.A.5
Gao, Z.G.6
-
230
-
-
0033513455
-
Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats
-
Xu, G., Stoffers, D. A., Habener, J. F., and Bonner-Weir, S. (1999). Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48, 2270-2276.
-
(1999)
Diabetes
, vol.48
, pp. 2270-2276
-
-
Xu, G.1
Stoffers, D.A.2
Habener, J.F.3
Bonner-Weir, S.4
-
231
-
-
28544441759
-
Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer
-
Yeh, A. H., Jeffery, P. L., Duncan, R. P., Herington, A. C., and Chopin, L. K. (2005). Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin. Cancer Res. 11, 8295-8303.
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 8295-8303
-
-
Yeh, A.H.1
Jeffery, P.L.2
Duncan, R.P.3
Herington, A.C.4
Chopin, L.K.5
-
232
-
-
39149108820
-
The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer
-
Yoo, Y. A., Kim, Y. H., Kim, J. S., and Seo, J. H. (2008). The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer. Biochim. Biophys. Acta 1783, 438-447.
-
(2008)
Biochim. Biophys. Acta
, vol.1783
, pp. 438-447
-
-
Yoo, Y.A.1
Kim, Y.H.2
Kim, J.S.3
Seo, J.H.4
-
233
-
-
36549062060
-
Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors
-
Younan, S. M., and Rashed, L. A. (2007). Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors. Gen. Physiol. Biophys. 26, 181-193.
-
(2007)
Gen. Physiol. Biophys.
, vol.26
, pp. 181-193
-
-
Younan, S.M.1
Rashed, L.A.2
-
234
-
-
67649856866
-
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
-
Zidar, D. A., Violin, J. D., Whalen, E. J., and Lefkowitz, R. J. (2009). Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc. Natl. Acad. Sci. U.S.A. 106, 9649-9654.
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 9649-9654
-
-
Zidar, D.A.1
Violin, J.D.2
Whalen, E.J.3
Lefkowitz, R.J.4
|